Lost in translation: again, another failed neuroprotection trial.
Brew
Bruce James
BJ
D015526:AIDS Dementia Complex / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D000975:Antioxidants / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis / Q000378:metabolism; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards; D019610:Cytoprotection / Q000187:drug effects* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009410:Nerve Degeneration / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D009414:Nerve Growth Factors / Q000187:drug effects / Q000378:metabolism; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D012642:Selegiline / Q000627:therapeutic use; D017211:Treatment Failure
D000975:Antioxidants; D015415:Biomarkers; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents; D012642:Selegiline